StemCell Therapy

Critical considerations in ensuring patient access to cell and gene therapies, and continued industry growth, include proper understanding of how to manage source material quality and supply chain continuity. The following areas will be covered:

The importance of defining source material requirements for translation of allogeneic advanced therapies The value of a reliable and recallable donor network for consistent source material access The critical requirements for obtaining GMP-compliant source materials for commercial manufacture Best practice in handling, monitoring and delivering temperature-sensitive source materials The importance of early planning, coordination and communication with all stakeholders

The webinar will take place on 12 March 2020 at 9:00 PDT / 12:00 EDT / 16:00 GMT / 17:00 CET.

Biocairs industry-leading service offering for cell and gene therapy logistics includes:

Dedicated project management teams including customer support specialists A global network of liquid nitrogen service stations 24/7 collection and delivery across the world A level of flexibility in service provision unrivalled in the industry

To register for the webinar visit http://www.biocair.com/events or contact marketing@biocair.com for more information.

Image: The webinar will be hosted by BIOINSIGHTS

See more here:
Biocair participates in cell and gene webinar alongside HemaCare and Beam Therapeutics - Cambridge Network

This entry was posted on February 27, 2020 at 8:44 pm and is filed under Gene therapy. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |